In Brief: Shark cartilage/cancer study
This article was originally published in The Tan Sheet
Shark cartilage/cancer study: Phase I/II trial of the safety and efficacy of shark cartilage in the treatment of advanced cancers finds that "shark cartilage was inactive in patients with advanced stage cancer and, specifically, in patients with breast, colon, lung and prostate cancer," Dennis Miller, Cancer Treatment Research Foundation, Arlington Heights, Ill., et al. concludes. The trial, the largest reported to date, entered 58 adults: 15 with breast cancer; 15 with colon cancer; 14, lung; eight, prostate; three, lymphoma; one, brain; and two, unknown. The abstract was presented at the annual meeting of the American Society of Clinical Oncology May 17-20 in Denver, Colo...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC